Non-Small Cell Lung Cancer Coverage from Every Angle
Editor:
David S. Ettinger, MD
Advertisement
Advertisement

David J. Kwiatkowski, MD, PhD, on Clinical Implications of Neoadjuvant Atezolizumab for Resectable Non–Small Cell Lung Cancer

Shirish M. Gadgeel, MD, on Advanced Non–Small Cell Lung Cancer: Integrating Chemotherapy and Immunotherapy
Suresh S. Ramalingam, MD, on Managing Pyrexia With Dabrafenib/Trametinib in Advanced NSCLC
Recent
News

ASCO 2019: Interim Results With Neoadjuvant Atezolizumab in Resectable Lung Cancer

ASCO 2019: Proton Therapy Versus Conventional Photon Therapy in Locally Advanced Cancer

ASCO 2019: Comparing Maintenance Therapies for Nonsquamous Lung Cancer

ASCO 2019: Neoadjuvant Combination Checkpoint Blockade in Early-Stage NSCLC

View More >
Published
Medical Literature

Adding Bevacizumab to Carboplatin/Pemetrexed in Nonsquamous NSCLC

Innovative Drug Delivery System in Lung Cancer: Combining Quantum Dots and TKIs

Lifetime Incidence of Brain Metastasis in Elderly Survivors of Lung Cancer

Combining Plasma and Tissue Genotyping in EGFR-Mutant Lung Cancer

View More >
Ongoing
CE Activities

Proceedings from the 15th Annual Winter Lung Cancer Conference

Advanced Non-Small Cell Lung Ccancer Patient Management Simulator

An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer: Advanced Disease

View More >
Available
Clinical Trials

UCSF Helen Diller Family Comprehensive Cancer Center

Fred and Pamela Buffett Cancer Center

University of Michigan Comprehensive Cancer Center

University Hospitals Seidman Cancer Center

View More >
Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.